EW: NY Valves Reinforces Clinical Evidence Leadership; PROGRESS Baseline Data Released

Research evidence excerpt

EW: NY Valves Reinforces Clinical Evidence Leadership; PROGRESS Baseline Data Released

on Securities Inc., RBC

Capital Markets, LLC, RBC Europe Limited, RBC Capital Markets (Europe) GmbH, Royal Bank of Canada, Hong Kong Branch, Royal Bank of Canada, Singapore Branch

and Royal Bank of Canada, Sydney Branch. The information contained in this report has been compiled by RBC Capital Markets from sources believed to be reliable,

but no representation or warranty, express or implied, is made by Royal Bank of Canada, RBC Capital Markets, its affiliates or any other person as to its accuracy,

completeness or correctness. All opinions and estimates contained in this report constitute RBC Capital Markets' judgement as of the date of this report, are

subject to change without notice and are provided in good faith but without legal responsibility. Nothing in this report constitutes legal, accounting or tax advice or

individually tailored investment advice. This material is prepared for general circulation to clients and has been prepared without regard to the individual financial

circumstances and objectives of persons who receive it. The investments or services contained in this report may not be suitable for you and it is recommended

that you consult an independent investment advisor if you are in doubt about the suitability of such investments or services. This report is not an offer to sell or

a solicitation of an offer to buy any securities. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original

capital may occur. RBC Capital Markets research analyst compensation is based in part on the overall profitability of RBC Capital Markets, which includes profits

attributable to investment banking revenues.